MemorialCare Heart & Vascular Institute (MHVI), through its advanced research program, is participating in a CSL Behring-sponsored multi-center, Phase III clinical trial – "ApoA-I Event reducinG in Ischemic Syndromes II (AEGIS-II) – which is studying the removal of cholesterol from the arteries to reduce the risk of a second heart attack or stroke in patients.
March 08, 2022
MemorialCare Heart and Vascular Institute Participating in Global Study of CSL112 in Patients with Acute Coronary Syndrome (AEGIS-II)
March 8, 2022 – MemorialCare Heart & Vascular Institute (MHVI), through its advanced research program, is…
Read More
James de Lemos, M.D.
March 08, 2022
Addressing the Difficulty of Diagnosing Heart Attacks After Heart Surgery
Mrach 8, 2022 – Diagnosing heart attacks after heart surgery remains difficult due to shortcomings of current…
Read More
AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer.
March 07, 2022
AdvaMed Mourns the Passing of Wendy Siminski
March 7, 2022 — AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice…
Read More
In January, The University of Maryland School of Medicine (UMSOM) and the University of Maryland Medical Center (UMMC) successfully executed a groundbreaking porcine heart transplant procedure in a human. This was the first successful transplant of a genetically modified pig’s heart into a human patient.
By Melinda Taschetta-Millane
March 04, 2022
DAIC’s Top 10 for the Month of February
Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of…
Read More
NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases, today announced dose administration for the first patient in its PREVAIL study, a global Phase 3 cardiovascular outcomes trial of the novel cholesteryl ester transfer protein (CETP) inhibitor obicetrapib
March 04, 2022
NewAmsterdam Pharma Doses First Patient in its PREVAIL Study
March 4, 2022 – NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of…
Read More
CIRCA S-CATH M esophageal temperature probe
March 03, 2022
CIRCA Scientific Receives FDA Clearance for New Esophageal Temperature Probe
March 3, 2022 – CIRCA Scientific, Inc. has announced that its S-CATH M Esophageal Temperature Probe is now cleared for…
Read More
Spontaneous coronary artery dissection (SCAD), a tear in an artery supplying blood to the heart, is a common cause of serious or fatal heart attacks that occur in women under age 50.
March 03, 2022
Common Cause of Heart Attacks in Younger Adults Linked to Gene Variants
March 3, 2022 – Spontaneous coronary artery dissection (SCAD), a tear in an artery supplying blood to the heart, is a…
Read More
The University of Maryland School of Medicine’s Institute of Human Virology, a Global Virus Network (GVN) Center of Excellence, physician researchers played a collaborative role in last month’s successful transplant of a genetically-modified pig heart into a patient with terminal heart disease by creating pathogen surveillance strategies and developing an infection prevention strategy for this unprecedent significant medical advancement.
March 03, 2022
Experts Perform Pathogen Surveillance for Unprecedented Pig-to-Human Heart Transplant
March 3, 2022 – The University of Maryland School of Medicine’s Institute of Human Virology, a Global Virus Network (…
Read More
As 1-year-old SaRyia Moore and her family celebrate American Heart Month, they do so will full, grateful hearts — including SaRyia's transplanted heart she received just eight weeks ago, saving her young life.
March 02, 2022
Texas Children's Hospital Passes Milestones of More Than 500 Heart Transplants, 2,000 Solid Organ Transplants
March 2, 2022 – As 1-year-old SaRyia Moore and her family celebrate American Heart Month, they do so will full,…
Read More
John Farquhar
March 02, 2022
HeartFlow Announces CEO Transition
March 2, 2022  – HeartFlow, Inc. has announced that John Farquhar has been appointed President and Chief Executive…
Read More
An international study led by a researcher from Tel Aviv University offers a novel technology that can assist many patients implanted with bioprosthetic heart valve by avoiding additional complicated replacement surgery.
March 02, 2022
Novel Technology Could Prevent Repeat Operations to Replace a Faulty Bioprosthetic Heart Valve
March 2, 2022 – An international study led by a researcher from Tel Aviv University offers a novel technology that can…
Read More
Students and faculty
March 01, 2022
Harding University Offering Nation's First Master of Science in Cardiac Function and Interventional Technology Program
  March 1, 2022 – To meet the growing industry demand for highly trained clinical professionals specializing in…
Read More
The same thing can be said for a heart with mitral valve prolapse (MVP) — as the diseased valve enlarges, the cords connected to the heart tissue feel stress and respond accordingly with stiffness and scarring, according to a recent paper in the Journal of the American Heart Association. 
March 01, 2022
Earlier Surgical Intervention Could Stave Off Fibrosis in People with Mitral Valve Prolapse
March 1, 2022 – The larger the sail, the more wind it catches. But as that size increases, so does the stress…
Read More
Parag Joshi, M.D.
March 01, 2022
High CAC, High Cholesterol Increase Heart Attack and Stroke Risk, UT Southwestern Cardiologists Find
March 1, 2022 – Patients with both a high lipoprotein(a) and high coronary artery calcium score (CAC) face a more than…
Read More
Anand Chockalingam
March 01, 2022
Adolescent Psychological Well-being Tied to Adult Risk of Cardiovascular Disease, Study Finds
March 1, 2022 – Scientists have known for years that a person’s risk of cardiovascular disease (CVD) can be lowered…
Read More
A new report says the wearable healthcare devices market is anticipated to grow at a CAGR of 13% from $16 billion in 2021 to $61 billion by 2032.
March 01, 2022
Wearable Healthcare Devices Market to Value $61 Billion by 2032
March 1, 2022 – A new report says the wearable healthcare devices market is anticipated to grow at a CAGR of 13% from $…
Read More
iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement of cardiac care, announced that the results of the KP-Rhythm2 study, titled “Diagnostic yield, outcomes and resource utilization with different ambulatory electrocardiographic monitoring strategies,” were published in the American Journal of Cardiology (AJC).
February 28, 2022
Zio by iRhythm Shows Significantly Higher Documentation of Atrial Fibrillation and Atrial Flutter Compared to Holter Monitors, Event Monitors
February 28, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the…
Read More
CGuard Carotid Stent
February 28, 2022
InspireMD Announces the Inclusion of its CGuard Carotid Stent in CREST-2 Trial
February 28, 2022 – InspireMD, Inc., a global developer of the CGuard Embolic Prevention Stent System (EPS) device for…
Read More
TRIA valve
February 28, 2022
TRIA Transcatheter Biopolymer Heart Valve Shows Promise in Pilot Animal Study
February 28, 2022 - Foldax, Inc. has announced the presentation of results from the first animal study of its…
Read More
WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device
February 28, 2022
Late-Breaking Study Results Reinforce Positive Real-World Outcomes with the WATCHMAN FLX LAAC Device
February 28, 2022 – Boston Scientific Corporation has announced positive results from a new analysis assessing real-…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now